Cutting the cost of drug development?
Cutting the cost of drug development?
复制标题
DOI：
10.1038/nrd1347
复制
发表时间：
2004-04-01
影响因子：
120.1
通讯作者：
Rawlins, MD
中科院分区：
文献类型：
--
作者：
Rawlins, MD
在过去的30年里，药物开发的成本显著上升，研究报告的价值现在超过8亿美元。由于这些螺旋式上升的成本可能会使发展中公司和消费者越来越难以负担新药的开发，显然应该努力解决这个问题。应该对药物发现和开发过程的所有方面进行检查，以寻找潜在的成本节约，但我在这里特别关注当前的监管要求。
The cost of drug development has risen markedly in the past 30 years, with studies now reporting values exceeding US $800 million. As these spiralling costs threaten to make the development of new drugs increasingly unaffordable for both developing companies and consumers, it is clear that efforts should be made to address this problem. All aspects of the drug discovery and development process should be examined for potential cost savings, but I focus here in particular on the current regulatory requirements.